Cytosorbents Corp Quarterly Income Tax Expense (Benefit) in USD from Q3 2011 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary
Cytosorbents Corp quarterly/annual Income Tax Expense (Benefit) history and growth rate from Q3 2011 to Q3 2024.
  • Cytosorbents Corp Income Tax Expense (Benefit) for the quarter ending September 30, 2024 was $0.000.
  • Cytosorbents Corp annual Income Tax Expense (Benefit) for 2023 was -$814K, a 25.5% increase from 2022.
  • Cytosorbents Corp annual Income Tax Expense (Benefit) for 2022 was -$1.09M, a 48.4% decline from 2021.
  • Cytosorbents Corp annual Income Tax Expense (Benefit) for 2021 was -$736K, a 34.7% increase from 2020.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Quarterly (USD)
Income Tax Expense (Benefit), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $0 $0 Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-07
Q3 2023 $0 $0 Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-07
Q4 2022 -$1.09M -$1.09M -$357K -48.4% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-15
Q3 2022 -$736K $0 $0 Jul 1, 2022 Sep 30, 2022 10-Q 2022-11-03
Q2 2022 -$736K $0 $0 Apr 1, 2022 Jun 30, 2022 10-Q 2022-08-02
Q1 2022 -$736K $0 $0 Jan 1, 2022 Mar 31, 2022 10-Q 2022-05-03
Q4 2021 -$736K -$736K +$391K +34.7% Oct 1, 2021 Dec 31, 2021 10-K 2024-03-15
Q3 2021 -$1.13M $0 $0 Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-03
Q2 2021 -$1.13M $0 $0 Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-02
Q1 2021 -$1.13M $0 $0 Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-03
Q4 2020 -$1.13M -$1.13M -$34.6K -3.17% Oct 1, 2020 Dec 31, 2020 10-K 2023-03-09
Q3 2020 -$1.09M $0 $0 Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-04
Q2 2020 -$1.09M $0 $0 Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-03
Q1 2020 -$1.09M $0 $0 Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-04
Q4 2019 -$1.09M -$1.09M -$473K -76.3% Oct 1, 2019 Dec 31, 2019 10-K 2022-03-10
Q3 2019 -$620K $0 $0 Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-04
Q2 2019 -$620K $0 $0 Apr 1, 2019 Jun 30, 2019 10-Q 2019-08-06
Q1 2019 -$620K $0 $0 Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-05
Q4 2018 -$620K -$620K +$57.2K +8.45% Oct 1, 2018 Dec 31, 2018 10-K 2021-03-09
Q3 2018 -$677K $0 $0 Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-05
Q2 2018 -$677K $0 $0 Apr 1, 2018 Jun 30, 2018 10-Q 2018-08-02
Q1 2018 -$677K $0 $0 Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-07
Q4 2017 -$677K -$677K -$358K -112% Oct 1, 2017 Dec 31, 2017 10-K 2020-03-05
Q3 2017 -$319K $0 $0 Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-06
Q2 2017 -$319K $0 $0 Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-02
Q1 2017 -$319K $0 $0 Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-08
Q4 2016 -$319K -$319K +$6.06K +1.87% Oct 1, 2016 Dec 31, 2016 10-K 2019-03-07
Q3 2016 -$325K $0 $0 Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-09
Q2 2016 -$325K $0 $0 Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-07
Q1 2016 -$325K $0 $0 Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-08
Q4 2015 -$325K -$325K Oct 1, 2015 Dec 31, 2015 10-K 2018-03-08
Q3 2015 $0 Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-07
Q2 2015 $0 Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-09
Q1 2015 $0 Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-09
Q3 2012 $0 $0 Jul 1, 2012 Sep 30, 2012 10-Q 2012-11-21
Q3 2011 $0 Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-21
* An asterisk sign (*) next to the value indicates that the value is likely invalid.